Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning. | Int J Mol Sci | 2023 | 37685980 | PubTator, text mining | PubMed |
| SUPREME: multiomics data integration using graph convolutional networks. | NAR Genom Bioinform | 2023 | 37680392 | PubTator, text mining | PubMed |
| Case report: A rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of PKLR and UGT1A1 mutation. | Front Genet | 2023 | 37671043 | PubTator, text mining | PubMed |
| MALAT1-regulated gene expression profiling in lung cancer cell lines. | BMC Cancer | 2023 | 37667226 | PubTator, text mining | PubMed |
| Nuclease genes occupy boundaries of genetic exchange between bacteriophages. | NAR Genom Bioinform | 2023 | 37636022 | PubTator, text mining | PubMed |
| High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer. | Genes (Basel) | 2023 | 37628611 | PubTator, text mining | PubMed |
| Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer. | Aging (Albany NY) | 2023 | 37602872 | PubTator, text mining | PubMed |
| Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer. | Sci Rep | 2023 | 37598257 | PubTator, text mining | PubMed |
| CALFAN (Low γ-Glutamyl Transpeptidase (GGT) Cholestasis, Acute Liver Failure, and Neurodegeneration) Syndrome: A Case Report with 3-Year Follow-Up after Liver Transplantation in Early Adulthood. | Case Reports Hepatol | 2023 | 37554250 | PubTator, text mining | PubMed |
| Revisited role of the placenta in bile acid homeostasis. | Front Physiol | 2023 | 37546542 | PubTator, text mining | PubMed |
| A novel cuproptosis-related genes model in breast cancer prognosis. | Medicine (Baltimore) | 2023 | 37543823 | PubTator, text mining | PubMed |
| Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center. | Int J Hepatol | 2023 | 37520499 | PubTator, text mining | PubMed |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. | J Pers Med | 2023 | 37511794 | PubTator, text mining | PubMed |
| EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications. | Curr Issues Mol Biol | 2023 | 37504297 | PubTator, text mining | PubMed |
| A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. | BMC Med Genomics | 2023 | 37488596 | PubTator, text mining | PubMed |
| The expression profiles of signature genes from CD103+LAG3+ tumour-infiltrating lymphocyte subsets predict breast cancer survival. | BMC Med | 2023 | 37488535 | PubTator, text mining | PubMed |
| Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. | PLoS One | 2023 | 37471416 | PubTator, text mining | PubMed |
| Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer. | Front Oncol | 2023 | 37469408 | PubTator, text mining | PubMed |
| ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest. | BMC Bioinformatics | 2023 | 37468832 | PubTator, text mining | PubMed |
| Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer. | Nat Commun | 2023 | 37463901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=10